Movers roundup: Celgene, Clovis Oncology

Movers roundup: Celgene shares rise on cancer drug study; Clovis shares fall

Associated Press

Among the stock activity stories for Monday, Nov. 12, from AP Business News:

— Celgene Corp. shares rose after the drug maker said that its cancer drug Abraxane improved survival for patients with advanced pancreatic cancer.

— Shares of Clovis Oncology Inc. fell after the company said its drug CO-101 failed in a clinical trial as a treatment for pancreatic cancer.

Rates

View Comments (0)